About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02268513

Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study

It has been argued that social relationships are important to health and well-being. This study will investigate links between social networks and cardiovascular disease risk factors in South Asians, ...

Lead sponsor: Northwestern University•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Northwestern University

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

This study will use mixed-methods to investigate links between social networks and cardiovascular disease risk factors in South Asians, the second fastest growing ethnic group in the US and one with disparate rates of coronary heart disease. Identifying and understanding the links between social networks and cardiovascular disease is key to the development and testing of family- and community-level prevention interventions for minorities.

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participants enrolled in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.

Exclusion Criteria

•People not enrolled in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.

Related studies

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT01399385 · Healthy, Obesity, and more

Causes and Natural History of Dyslipidemias

NCT00353782 · Hypercholesterolemia, Atherosclerosis

RECRUITINGPhase 3

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

NCT07241390 · Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT01143454 · Metabolic Disease, Obesity, and more

A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis

NCT05316311 · Intracranial Atherosclerosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 21, 2018Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment775

Start dateSep 2014

Last updatedAug 21, 2018

Condition

Atherosclerosis

Locations shown

University of California at San Francisco

San Francisco, California

Northwestern University

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 21, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions